Holen Sie sich die Stockscreener-App
7.55
8.37%
-0.69
Vorhandelsmarkt:
7.60
0.05
+0.66%
Schlusskurs vom Vortag:
$8.24
Offen:
$8.06
24-Stunden-Volumen:
44,737
Relative Volume:
0.12
Marktkapitalisierung:
$15.30M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-25.56M
KGV:
-1.4519
EPS:
-5.2
Netto-Cashflow:
$-19.35M
1W Leistung:
-6.21%
1M Leistung:
+605.61%
6M Leistung:
+291.19%
1J Leistung:
+85.41%
1-Tages-Spanne:
$7.38
$8.3988
1-Wochen-Bereich:
$7.24
$9.09
52-Wochen-Spanne:
$0.62
$9.56
Biovie Inc Stock (BIVI) Company Profile
Firmenname
Biovie Inc
Sektor
Branche
Telefon
775-888-3162
Adresse
680 W NYE LANE, CARSON CITY
Vergleichen Sie BIVI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BIVI
Biovie Inc
|
7.55 | 15.30M | 0 | -25.56M | -19.35M | -5.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Biovie Inc Stock (BIVI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-07-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-01-15 | Eingeleitet | B. Riley Securities | Buy |
Biovie Inc Aktie (BIVI) Neueste Nachrichten
What drives BioVie Inc. stock priceUnprecedented market success - Autocar Professional
Is BioVie Inc. stock overhyped or has real potentialTremendous wealth creation - jammulinksnews.com
Biovie shares climb as Alzheimer’s drug shows promising age deceleration effects - MSN
Biovie stock rises after drug shows age deceleration in Alzheimer’s patients - Investing.com Australia
BioVie presents data on Bezisterim at WCAG-2025 - TipRanks
BioVie Inc. Presents Promising Phase 3 Study Results for Bezisterim in Alzheimer’s Disease at WCAG-2025 - Quiver Quantitative
Breakthrough: New Alzheimer's Drug Bezisterim Reverses Aging Across 10 Biological Markers, Trial Data Reveals - Stock Titan
BioVie Expands Board Amid Drug Development Momentum - TipRanks
Is BioVie Inc. a good long term investmentRobust investment performance - Autocar Professional
BioVie Inc. Stock Analysis and ForecastConsistently exceptional gains - jammulinksnews.com
BioVie appoints Amy Chappell, Kameel Farag to board of directors - TipRanks
BioVie Inc. Appoints Dr. Amy S. Chappell and Kameel D. Farag to Board of Directors - Quiver Quantitative
BioVie Appoints Industry Veterans Amy Chappell, MD, FAAN, and Kameel Farag to Board of Directors - GlobeNewswire
What analysts say about BioVie Inc. stockExceptional trading results - jammulinksnews.com
New to The Street Episode #679 Airs Tonight on Fox Business Network - New Castle News
What makes BioVie Inc. stock price move sharplyFree Consultation - beatles.ru
How high can BioVie Inc. stock price go in 2025Free Stock Market Practical Discussion Forums - beatles.ru
Why BioVie Inc. stock attracts strong analyst attentionFree Real-Time Market Predictions - Newser
How BioVie Inc. stock performs during market volatilityRisk Aware High Growth Picks - Newser
New to The Street Episode #678 to Air on Bloomberg TV Featuring Game-Changing Innovators in AI, Biotech, Blockchain, and Sustainability - The Des Moines Register
BioVie Inc. Presents Promising Data on Bezisterim's Effects on Aging and Neurodegeneration at World Aging and Rejuvenation Conference - Nasdaq
BioVie Announces Data Highlighting Bezisterim’s Potential to Slow or Reverse Biological Aging and Neurodegeneration Featured as a Keynote Talk at the 7th World Aging and Rejuvenation Conference - The Manila Times
Breakthrough Alzheimer's Drug Shows Unprecedented 4-Year Biological Age Reversal in Phase 3 Trial - Stock Titan
BioVie (NASDAQ:BIVI) Stock Price Down 15.6% – Should You Sell? - Defense World
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of BioVie Inc. (BIVI) - ACCESS Newswire
BioVie To Carry Out 1-for-10 Reverse Stock Split On July 7th, 2025 - 富途牛牛
BioVie Announces 1-for-10 Reverse Stock Split - TipRanks
New to The Street Announces the Broadcast of Show Number 675 This Saturday at 6:30 PM EST on Bloomberg Television Featuring: FLOKI, BioVie (NASDAQ: BIVI), Arrive AI ($ARAI), Health In Tech (NASDAQ HIT), and Commercialville T.V. - Foster's Daily Democrat
BioVie (BIVI) Highlights Innovative Clinical Trial at Upcoming C - GuruFocus
New to The Street Show Number 675 Airing This Saturday on Bloomberg Television Featuring FLOKI, BioVie, Arrive AI, Health In Tech, and Commercialville T.V. - AInvest
BioVie announces poster on patient-centric accessibility of SUNRISE-PD trial - TipRanks
Revolutionary Parkinson's Trial Brings Treatment Testing to Patients' HomesSee How It Works - Stock Titan
Finanzdaten der Biovie Inc-Aktie (BIVI)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.32%
1.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):